These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30094404)

  • 21. Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.
    Liu K; Wong VW; Lau K; Liu SD; Tse YK; Yip TC; Kwok R; Chan AY; Chan HL; Wong GL
    Am J Gastroenterol; 2017 Dec; 112(12):1812-1823. PubMed ID: 29087391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J
    Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
    Elhence A; Anand A; Biswas S; Vaishnav M; Yadav R; Das P; Panwar R; Agarwal S; Gamanagatti S; Kumar R; Shalimar
    Dig Dis Sci; 2023 Mar; 68(3):1016-1025. PubMed ID: 35670897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
    Grgurevic I; Madir A; Trkulja V; Bozin T; Aralica G; Podrug K; Mikolaševic I; Tsochatzis E; O'Beirne J; Pinzani M
    Eur J Clin Invest; 2022 Jun; 52(6):e13750. PubMed ID: 35040495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.
    Kuchay MS; Choudhary NS; Sharma D; Krishan S; Mishra SK; Wasir JS; Singh MK; Saraf N; Dhampalwar S; Sud R
    J Clin Exp Hepatol; 2022; 12(3):893-898. PubMed ID: 35677514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining values for controlled attenuation parameter and liver stiffness in youth without liver disease.
    Ramírez-Vélez R; García-Hermoso A; Correa-Rodríguez M; Izquierdo M
    Pediatr Res; 2022 Mar; 91(4):912-920. PubMed ID: 33846557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.
    Izumi T; Sho T; Morikawa K; Shigesawa T; Suzuki K; Nakamura A; Ohara M; Kawagishi N; Umemura M; Shimazaki T; Kimura M; Nakai M; Suda G; Natsuizaka M; Ogawa K; Kudo Y; Nishida M; Ono K; Baba M; Furuya K; Sakamoto N
    Hepatol Res; 2019 Oct; 49(10):1207-1217. PubMed ID: 31219667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years.
    Zeng J; Zhang X; Sun C; Pan Q; Lu WY; Chen Q; Huang LS; Fan JG
    BMC Pediatr; 2019 Apr; 19(1):129. PubMed ID: 31018838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation.
    Duarte-Rojo A; Heimbach JK; Borja-Cacho D; Barone GW; Shaheen MF; Lamps LW; Graham RP; Tan EK; Concepcion W; Kim WR
    Transplantation; 2022 Feb; 106(2):318-327. PubMed ID: 33675319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.
    Shen F; Zheng RD; Shi JP; Mi YQ; Chen GF; Hu X; Liu YG; Wang XY; Pan Q; Chen GY; Chen JN; Xu L; Zhang RN; Xu LM; Fan JG
    Liver Int; 2015 Nov; 35(11):2392-400. PubMed ID: 25689614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension.
    Semmler G; Hartl L; Mendoza YP; Simbrunner B; Jachs M; Balcar L; Schwarz M; Hofer BS; Fritz L; Schedlbauer A; Stopfer K; Neumayer D; Maurer J; Szymanski R; Meyer EL; Scheiner B; Quehenberger P; Trauner M; Aigner E; Berzigotti A; Reiberger T; Mandorfer M
    Hepatology; 2024 Mar; ():. PubMed ID: 38447034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease.
    Pons M; Simón-Talero M; Millán L; Ventura-Cots M; Santos B; Augustin S; Genescà J
    Dig Liver Dis; 2016 Oct; 48(10):1214-9. PubMed ID: 27388262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient Elastography in the Diagnosis of Pediatric Non-alcoholic Fatty Liver Disease and Its Subtypes.
    Yang L; Zhu Y; Zhou L; Yin H; Lin Y; Wu G
    Front Pediatr; 2022; 10():808997. PubMed ID: 35433553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.
    Shen F; Zheng RD; Mi YQ; Wang XY; Pan Q; Chen GY; Cao HX; Chen ML; Xu L; Chen JN; Cao Y; Zhang RN; Xu LM; Fan JG
    World J Gastroenterol; 2014 Apr; 20(16):4702-11. PubMed ID: 24782622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.
    Pastrovic F; Madir A; Podrug K; Lucijanic M; Bokun T; Zelenika M; Mustapic S; Unic A; Derek L; Grgurevic I
    Biochem Med (Zagreb); 2022 Jun; 32(2):020712. PubMed ID: 35799983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
    Yu XY; Song XX; Tong YL; Wu LY; Song ZY
    Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students.
    Nastasa R; Stanciu C; Zenovia S; Singeap AM; Cojocariu C; Sfarti C; Girleanu I; Chiriac S; Cuciureanu T; Huiban L; Muzica CM; Trifan A
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis.
    Cuomo G; Iandoli C; Galiero R; Caturano A; Di Vico C; Perretta D; Adamo PV; Ferrara R; Rinaldi L; Romano C; Sasso FC
    Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.